Three new international trials for childhood cancers will be opened in Australia.
The Australian Government has announced that they will support two paediatric brain cancer trials and a rhabdomyosarcoma (RMS) trial through the Australian Brain Cancer Mission and the Medical Reach Future Fund.
The following ANZCHOG trials will be supported:
- Far-RMS - The Frontline and Relapse study in RMS
- COZMOS - A phase I/Ib trial of COmbined 5'-aZacitidine and carboplatin for recurrent/refractory paediatric brain and solid tuMOurs
- SJ ELiOT - St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain Tumours.
For further information, please see our ANZCHOG media release